FRSX vs CPSH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

FRSX

38.6
AI Score
VS
FRSX Wins

CPSH

36.3
AI Score

Investment Advisor Scores

FRSX

39score
Recommendation
AVOID NEW MONEY

CPSH

36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric FRSX CPSH Winner
Forward P/E 0 72.9927 Tie
PEG Ratio 0 0 Tie
Revenue Growth -32.8% 1.1% CPSH
Earnings Growth 0.0% 78.6% CPSH
Tradestie Score 38.6/100 36.3/100 FRSX
Profit Margin 0.0% 0.3% CPSH
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED CPSH

Relative Price Performance (Last 90 Days)

FRSX 1M: -31.0% · 3M: -56.3% CPSH 1M: +21.6% · 3M: +0.0%

Current Technical Phase

FRSX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.1%), weak momentum, RSI 24

RSI (14): 23.9 · Price: $0.58

CPSH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.9 · Price: $4.28

Fundamentals Snapshot

Metric FRSX CPSH
Market Cap — —
Forward P/E -0.2 71.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 0.0%
Gross Margin 0.7% 0.2%
Operating Margin -33.9% 0.0%
EPS -6.81 0.00
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, FRSX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.